Insider · CIK 0001860131

Audhya Paul K.

Reports to the SEC for 1 company · FRAMINGHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001860131

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	KalVista Pharmaceuticals, Inc.D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−150K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−100K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−25.8K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−40K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−68.8K sh	—	—	0
2026-06-11	KalVista Pharmaceuticals, Inc.Restricted Stock UnitD Disposition to Issuer	CHIEF MEDICAL OFFICER	DDisposition to Issuer	−93.8K sh	—	—	0
2026-05-26	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,239 sh	$26.78	−$60K	150,260
2026-05-22	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,685 sh	$26.78	−$71.9K	147,499
2026-05-22	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	—	—	152,499
2026-05-22	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	40,000
2026-05-21	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+6,250 sh	—	—	150,184
2026-05-21	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−6,250 sh	—	—	68,750
2026-05-18	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−1,032 sh	$26.76	−$27.6K	143,934
2026-05-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+2,419 sh	—	—	144,966
2026-05-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,419 sh	—	—	0
2026-04-17	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,686 sh	$20.22	−$54.3K	142,547
2026-04-16	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+6,250 sh	—	—	145,233
2026-04-16	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−6,250 sh	—	—	93,750
2026-02-23	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−5,354 sh	$15.57	−$83.3K	138,983
2026-02-22	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	—	—	144,337
2026-02-22	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	45,000
2026-02-21	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+6,250 sh	—	—	139,337
2026-02-21	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−6,250 sh	—	—	75,000
2026-02-18	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−1,163 sh	$15.00	−$17.4K	133,087
2026-02-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+2,419 sh	—	—	134,250
2026-02-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,419 sh	—	—	2,419
2026-01-16	KalVista Pharmaceuticals, Inc.Restricted Stock UnitA Award	CHIEF MEDICAL OFFICER	AAward	+100K sh	—	—	100,000
2025-11-24	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−5,296 sh	$13.45	−$71.2K	131,831
2025-11-22	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	—	—	137,127
2025-11-22	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	50,000
2025-11-21	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+6,250 sh	—	—	132,127
2025-11-21	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−6,250 sh	—	—	81,250
2025-11-18	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−3,075 sh	$14.48	−$44.5K	125,877
2025-11-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+6,447 sh	—	—	128,952
2025-11-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,419 sh	—	—	4,838
2025-11-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−4,028 sh	—	—	0
2025-08-25	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,336 sh	$13.42	−$31.3K	122,505
2025-08-22	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	—	—	124,841
2025-08-22	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	55,000
2025-08-22	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,942 sh	$13.22	−$38.9K	119,841
2025-08-21	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+6,250 sh	—	—	122,783
2025-08-21	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−6,250 sh	—	—	87,500
2025-08-18	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,939 sh	$13.19	−$38.8K	116,533
2025-08-17	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+6,446 sh	—	—	119,472
2025-08-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−2,418 sh	—	—	7,257
2025-08-17	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−4,028 sh	—	—	4,028
2025-05-23	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,146 sh	$11.31	−$24.3K	113,026
2025-05-22	KalVista Pharmaceuticals, Inc.S Sale	CHIEF MEDICAL OFFICER	SSale	−2,689 sh	$11.88	−$31.9K	110,172
2025-05-22	KalVista Pharmaceuticals, Inc.M Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	+5,000 sh	—	—	115,172
2025-05-22	KalVista Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	CHIEF MEDICAL OFFICER	MExercise/Conversion	−5,000 sh	—	—	60,000

Recent filings

Accepted (ET)
Jun 114
Audhya Paul K.0001860131-26-000010
SEC(opens sec.gov)
May 274
Audhya Paul K.0001860131-26-000008
SEC(opens sec.gov)
May 264
Audhya Paul K.0001860131-26-000007
SEC(opens sec.gov)
May 194
Audhya Paul K.0001860131-26-000006
SEC(opens sec.gov)
Apr 204
Audhya Paul K.0001860131-26-000004
SEC(opens sec.gov)
Feb 244
Audhya Paul K.0001860131-26-000003
SEC(opens sec.gov)

Companies

KalVista Pharmaceuticals, Inc.CHIEF MEDICAL OFFICER

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702